MacroGenics, Inc. (MGNX) Earnings History
Annual and quarterly earnings data from 2011 to 2025
Loading earnings history...
MGNX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MGNX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 0.0% | -48.7% | -49.9% |
| 2024 | 91.7% | -74.5% | -45.1% |
| 2023 | 85.6% | -294.2% | -15.8% |
| 2022 | 95.1% | -80.9% | -79.8% |
| 2021 | 96.5% | -268.1% | -267.2% |
Download Data
Export MGNX earnings history in CSV or JSON format
Free sign-in required to download data
MacroGenics, Inc. (MGNX) Earnings Overview
As of May 6, 2026, MacroGenics, Inc. (MGNX) reported trailing twelve-month net income of -$75M, reflecting -10.3% year-over-year growth. The company earned $-1.18 per diluted share over the past four quarters, with a net profit margin of -49.9%.
Looking at the long-term picture, MGNX's historical earnings data spans multiple years. The company achieved its highest annual net income of $8M in fiscal 2012.
MacroGenics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCUS (-$369M net income, -142.9% margin), FATE (-$136M net income, -2051.1% margin), IMVT (-$464M net income), MGNX has outperformed on profitability metrics. Compare MGNX vs RCUS →
MGNX Earnings vs Peers
Earnings metrics vs comparable public companies
MGNX Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$75M | -11.4% | -$73M | $-1.18 | -49.9% | -48.7% |
| 2024 | -$67M | -639.3% | -$111M | $-1.07 | -45.1% | -74.5% |
| 2023 | -$9M | +92.4% | -$168M | $-0.15 | -15.8% | -294.2% |
| 2022 | -$120M | +40.7% | -$121M | $-1.95 | -79.8% | -80.9% |
| 2021 | -$202M | -55.8% | -$203M | $-3.18 | -267.2% | -268.1% |
| 2020 | -$130M | +14.5% | -$131M | $-2.25 | -132.7% | -134.1% |
| 2019 | -$152M | +11.5% | -$177M | $-3.16 | -244.8% | -285.7% |
| 2018 | -$171M | -773.6% | -$171M | $-4.19 | -285.2% | -284.8% |
| 2017 | -$20M | +66.5% | -$22M | $-0.54 | -12.6% | -14.2% |
| 2016 | -$59M | -190.6% | -$60M | $-1.69 | -67.6% | -69.3% |
See MGNX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MGNX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MGNX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMGNX — Frequently Asked Questions
Quick answers to the most common questions about buying MGNX stock.
Is MGNX growing earnings?
MGNX EPS fell to $-1.18, with earnings declining -10.3%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-75M.
What are MGNX's profit margins?
MacroGenics, Inc. net margin is -49.9%, with operating margin at -48.7%. Below-average margins reflect competitive or cost pressures.
How consistent are MGNX's earnings?
MGNX earnings data spans 2011-2025. The declining earnings trend is -10.3% YoY. Historical data enables comparison across business cycles.